Successful explantation of a corneal microlens for presbyopia and implantation of a trifocal IOL in a patient who developed ...
The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for LNZ100 (aceclidine 1.75% ophthalmic solution) for the treatment of presbyopia. LNZ100 is a single-use, ...
Please provide your email address to receive an email when new articles are posted on . Staff can be trained to collect information about patients’ lifestyles from ...
If you’re over age 40 and you notice that words are starting to seem blurrier when you read, you’re not going crazy. There’s a good chance you’re experiencing presbyopia. Presbyopia is an age-related, ...
A Prescription Drug User Fee Act target date of January 28, 2026 has been set for the application. The Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for Brimochol ™ ...
The US Food and Drug Administration has approved a landmark eye drop that uses a combined dose of medication to restore age-related near-sightedness, without the need for surgery, for a longer ...
Viatris Inc. (NASDAQ:VTRS) is one of the most undervalued stocks under $30 to buy. On February 25, Viatris announced that the FDA accepted its sNDA for MR-141, which is a phentolamine ophthalmic ...
Launched VIZZ® (aceclidine ophthalmic solution) 1.44% for the treatment of presbyopia in October 2025 and generated net product revenues of $1.6 ...
RESEARCH TRIANGLE PARK, N.C., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical company developing gene ...
PITTSBURGH, Feb. 25, 2026 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the ...
One day the nutrition label on your cereal box is clear as day. The next day the letters and numbers look like an army of fuzzy dots. Presbyopia age-related farsightedness that typically begins around ...